¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"positive regulation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • chromatin-positive
    ¿°»öÁú¾ç¼º-
  • false positive
    °ÅÁþ¾ç¼º, °¡¾ç¼º
  • false positive reaction
    °ÅÁþ¾ç¼º¹ÝÀÀ, °¡¾ç¼º¹ÝÀÀ
  • gram-positive
    ±×¶÷¾ç¼º-
  • gram-positive bacterium
    ±×¶÷¾ç¼º±Õ
  • intermittent positive pressure breathing
    °£Çæ¾ç¾ÐÈ£Èí
  • intermittent positive pressure ventilation
    °£Çæ¾ç¾Ðȯ±â(¹ý)
  • positive
    1. ¾ç¼º- 2. ±àÁ¤-
  • positive acceleration
    ¾ç¼º°¡¼Óµµ
  • positive afterimage
    ¾ç¼ºÀÜ»ó
  • positive convergence
    ¾ç¼º´«¸ðÀ½
  • positive conversion
    ¾ç¼ºÀüȯ
  • positive declination
    ¿Üȸ¼±
  • positive dromotropism
    ÃËÁøÀüµµ¿µÇ⼺, º¯Á¶Áõ°¡
  • positive end expiratory pressure
    ³¯¼û³¡¾ç¾Ð, È£±â¸»¾ç¾Ð
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • automatic intermittent positive pressure respirator
    ÀÚµ¿°£Çæ¾ç¾ÐÈ£Èí±â
  • positive acceleration
    ¾ç¼º°¡¼Ó
  • positive afterimage
    ¾ç¼ºÀÜ»ó
  • biologic false positive reaction
    »ý¹°ÇÐÀû°ÅÁþ¾ç¼º¹ÝÀÀ
  • continuous positive pressure breathing
    Áö¼Ó¼º¾ç¾ÐÈ£Èí(¹ý)
  • Gram-positive bacterium
    ±×¶÷¾ç¼º±Õ
  • intermittent positive pressure breathing
    °£Çæ¾ç¾ÐÈ£Èí
  • positive pressure breathing
    ¾ç¾ÐÈ£Èí(¹ý)
  • continuous positive airway pressure
    Áö¼Ó¼º±âµµ¾ç¾Ð
  • positive convergence
    ¾ç¼º´«¸ðÀ½
  • positive conversion
    ¾çÀü
  • positive declination
    ¿Üȸ¼±
  • positive dromotropism
    ÃËÁøÀüµµ¿µÇ⼺, ¹æ½ÇÀüµµÃËÁø
  • false-positive
    °ÅÁþ¾ç¼º
  • false positive reaction
    °ÅÁþ¾ç¼º¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • PANSS=Positive and Negative Syndrome Scale
    ¾ç¼º À½¼º ÁõÈıº ôµµ
  • PEEP(positive end-expiratory pressure)
    È£±â¸» ¾ç¾ÐÈ£Èí
  • Rh positive
    Rh ¾ç¼º
  • SAPS, Scale for the Assessment of Positive Symptoms
    ¾ç¼ºÁõ»óÆò°¡Ã´µµ
  • gram positive organism
    ±×·¥¾ç¼º¼¼±Õ.
  • hallucination, positive
    ¾ç¼ºÈ¯°¢(åÕàõü³ÊÆ)
  • high frequency positive pressure ventilation =HFPPV
    °íºóµµ¾ç¾Ðȯ±â.
  • positive acceleration
    ¾ç°¡¼Óµµ(Çö»ó)(åÕÊ¥áÜöôúÞßÚ).
  • positive after image
    ¾ç¼ºÀÜ»ó(åÕàõíÑßÀ).
  • positive after potential
    ¾ç¼ºÈÄÀüÀ§(åÕàõý­ï³êÈ).
  • positive afterimage
    ¾ç¼ºÀÜ»ó
  • positive airway pressure
    ±âµµ¾ç¾Ð(ѨԳ åÕäâ).
  • positive balance
    ¾ç¼º¼öÁö.
  • positive charge
    ¾çÀüÇÏ(åÕï³ùÃ).
  • positive chronotropic
    ½É¹Úµ¿Áõ°¡.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • regulation
    ±ÔÁ¤
  • regulation of acid base equilibrium
    »ê-¿°±âÆòÇüÁ¶Àý(ß«ç¤ÐñøÁû¬ðàï½).
  • regulation of body temperature
    ü¿ÂÁ¶Àý(ô÷è®ðàï½).
  • regulation of gastric secretion
    À§»êºÐºñÁ¶Àý(êÖß«ÝÂù²ðàï½).
  • respiration regulation
    È£ÈíÁ¶Àý.
  • self regulation
    ÀÚ°¡Á¶Àý(í»Ê«ðàï½).
  • temperature regulation
    ü¿ÂÁ¶Àý(ô÷è® ðàï½).
  • toxic chemical regulation
    µ¶¼ºÈ­Çй°Áú±ÔÁ¤
  • automatic intermittent positive pressure
    ÀÚµ¿°£ÇæÀû ¾ç¾ÐÈ£Èí±â.
  • automatic intermittent positive pressure respir ator
    ÀÚµ¿°£ÇæÀû ¾ç¾ÐÈ£Èí±â.
  • automatic intermittent positive pressure respirator
    ÀÚµ¿°£ÇæÀû ¾ç¾ÐÈ£Èí±â.
  • bacterium, Gram-positive
    ±×¶÷¾ç¼º¼¼±Õ
  • biologic false positive reaction
    »ý¹°ÇÐÀû °¡¾ç¼º ¹ÝÀÀ(¡­Ê£åÕàõÚãëë).
  • biologic false positive serologic test
    »ý¹°ÇÐÀû °¡¾ç¼º Ç÷û¹ÝÀÀ(¡­Ê£åÕàõ úìôèÚãëë).
  • biological false positive reaction
    »ý¹°ÇÐÀû °¡¾ç¼º ¹ÝÀÀ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • positive supercoil
    ¾ç¼º(åÕàõ) ¼öÆÛÄÚÀÏ
  • positive superhelix
    ¾ç¼º(åÕàõ) ¼öÆÛ³ª¼±(Õ¢àÁ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PPV pneumococcal polysaccharide vaccine; porcine parvovirus; positive predictive value; positive pressur...
CPAP Continuous Positive Airway Pressure
CPPV Continuous Positive Pressure Ventilation
HEMPAS Test Hereditary Erythrocytic Multinuclearity with Positive Acidified Serum Test
IPPB Intermittent Positive Pressure Breathing; °£ÇæÀû ¾ç¾Ð È£Èí
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CPAP Continuous Positive Airway Pressure
CPPV Continuous Positive Pressure Ventilation
ER+ Estrogen receptor-positive
EPAP Expiratory positive airway pressure
FP False positive
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • continuous positive airway pressure
    Áö¼Ó¼º ±âµµ ¾ç¾Ð
  • false positive reaction
    °¡¾ç¼º ¹ÝÀÀ
  • false-positive diagnosis
    À§ ¾ç¼º Áø´Ü
  • intermittent positive pressure breathing
    °£ÇæÀû Á¤¾Ð È£Èí¹ý
    ¼øÈ¯ÆÇÀ¸·ÎºÎÅÍÀÇ ÀÏÁ¤ ¾Ð·ÂÇÏ¿¡¼­ ÈíÀÔÇÏ´Â µ¿¾È¿¡ Æó°¡ ÀÚµ¿ÀûÀ¸·Î ÆØÃ¢ÇÏ´Â °Í.
  • positive
    ¾ç¼º, ¾çÀÇ, ¾ç¼ºÀÇ, ¹Ù¸¥
  • positive after potential
    ¾ç¼º ÈÄÀüÀ§
  • positive airway pressure
    ±âµµ ¾ç¾Ð
  • positive aspect
    ÁÁÀº Ãø¸é
  • positive behavior
    ±àÁ¤ÀûÀΠŵµ
  • positive charge
    ¾ç ÀüÇÏ
  • positive communication
    ±àÁ¤ÀûÀÎ ´ëÈ­
  • positive convergence
    ¾ç¼º ´«¸ðÀ½, ¾ç¼º ÆøÁÖ
  • positive declination
    ¿Üȸ¼±
  • positive feedback loop
    ¾ç¼º µÇ¸ÔÀÌ±â °í¸®, ¾ç¼º Çǵå¹é °í¸®
  • positive habit history
    ¾ç¼ºÀÇ ½À°ü º´·Â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
negative regulation Negative feedback in biological systems mediated by allosteric regulatory enzymes.
(18 Nov 1997)
down-regulation <physiology> Development of a refractory or tolerant state consequent upon repeated administration of a pharmacologically or physiologically active substance.
It is the process that decreases ligand and receptor interactions or reduces the responsiveness of a cell to a stimulus following first exposure.
This is often accompanied by an initial decrease in affinity of receptors for the agent and a subsequent reduction in the number of available receptors expressed on the surface which can result from internalisation of the ligand:receptor complex or from decreased expression of the receptor.
Classically the concept referred to hormone receptors but contemporary usage includes other cell surface receptors.
(03 Jul 1999)
target regulation <physiology> General term for an interaction between neurons and their targets by which target derived signals influence the differentiation of the innervating neurons.
(18 Nov 1997)
enzyme regulation <biochemistry> Control of the rate of a reaction catalyzed by an enzyme by some effector (e.g., inhibitors or activators) or by alteration of some condition (e.g., pH or ionic strength).
(05 Mar 2000)
facility regulation and control Formal voluntary or governmental procedures and standards required of hospitals and health or other facilities to improve operating efficiency, and for the protection of the consumer.
(12 Dec 1998)
feedback regulation <physiology> Control mechanism that uses the consequences of a process to regulate the rate at which the process occurs: if, for example: the products of a reaction inhibit the reaction from proceeding (or slow down the rate of the reaction), then there is negative feedback, something that is very common in metabolic pathways.
Positive feedback is liable to lead to exponential increase and may be explosively dangerous in some cases.
Other examples are the action of voltage dependent sodium channels in generating action potentials and the activation of blood clotting factors V and VIII by thrombin. Without damping, feedback can lead to resonance (hunting) and oscillation in the system.
(18 Nov 1997)
up-regulation Opposite of down-regulation.
(05 Mar 2000)
up-regulation (physiology) Process that increases ligand/receptor interactions due to an increase in the number of available receptors.
(12 Dec 1998)
CD4-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the t4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes, which includes both the helper-inducer (T-lymphocytes, helper-inducer) and suppressor-inducer (T-lymphocytes, suppressor-inducer) T-cells.
(12 Dec 1998)
CD8-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-lymphocytes, cytotoxic) and suppressor T-lymphocytes (T-lymphocytes, suppressor-effector).
(12 Dec 1998)
gram-positive <microbiology> Bacteria that retain the stain or that are resistant to decolourisation by alcohol during Gram's method of staining.
This is a primary characteristic of bacteria whose cell wall is composed of a thick layer of peptidologlycan containing teichoic and lipoteichoic acid complexed to the peptidoglycan.
See: gram-negative
(06 Oct 1997)
gram-positive asporogenous rods <microbiology> A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common.
(12 Dec 1998)
gram-positive asporogenous rods, irregular <microbiology> A group of irregular rod-shaped bacteria that stain gram-positive and do not produce endospores.
(12 Dec 1998)
gram-positive asporogenous rods, regular <microbiology> A group of regular rod-shaped bacteria that stain gram-positive and do not produce endospores.
(12 Dec 1998)
gram-positive bacteria <microbiology> Bacteria which retain the crystal violet stain when treated by gram's method.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • positive law
    ½ÇÁ¤¹ý
  • positive lens
    Á¤·»Áî
  • positive number
    ¾ç¼ö
  • positive organ
    ½Ç³» ¿À¸£°£
  • positive philosophy
    ½ÇÁõ öÇÐ
  • positive plate
    ¾ç±ØÆÇ
  • positive pole
    ºÏ±Ø;¾ç±Ø
  • positive proof
    È®Áõ
  • positive ray
    ¾ç±Ø¼±
  • positive sign
    Ç÷¯½º ±âÈ£
  • positive term
    ½Ç¸í»ç
  • positive virtue
    Àû±ØÀû ¹Ì´ö;½ÇÇàÀ¸·Î ³ªÅ¸³»´Â ´ö !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á